Replies to post #194971 on Anavex Life Sciences Corp (AVXL)

[Lima4918]

I agree here w Xena. So we are 70% enrolled in PDD, 40% in Rhett, 20% in Alz and 18 months of cash available? Missing persuaded Kaufman to be our CMO. He persuaded Hampel to present our Alz data last year. He had something to do with our ability to join the global consortium, right? If you believe what the company said in their "unofficial" proxy mailing to shareholders then we know there is interest in Anavex, otherwise no mailing and no preferreds needed. Missing is copaneling with Mercks neurodisease guy at a conference in July, right?
All of this kind of moves the needle for me...

He is definitely not perfect, but, share price does affect investor sentiment. last weeks prices helped improve sentiment, even in me. Today I'm bummed out, to be very honest. But what has changed in one week?

Other than s&p becoming aware of Anavex and slapping a $15 NPV?

:)

PS the July panel discussion w Merck asks the question relating to precision medicine being effective in psychiatric diseases, and Merck wouldn't copanel with Anavex unless the answer was yes. And who is the precision medicine pioneer? Anavex is

[LakeshoreLeo1953]

NO....A successful manager hires individuals outside
their personal expertise BECAUSE they are successful managers.

Missling, for all his background, is not managing a large
number of people. Nor is he personally guiding the scientific
effort. For the purposes of this company to this point his
stewardship is primarily promotion and finance. A lively
debate can be had as to the success or failure in that regard.